Trial Profile
A double-blind, placebo controlled multi-centre study to evaluate the effects of topical Oxytocin on vaginal atrophy in postmenopausal women.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Oxytocin (Primary)
- Indications Atrophic vaginitis
- Focus Therapeutic Use
- Sponsors Peptonic Medical
- 16 Nov 2011 Status changed from active, no longer recruiting to completed as reported by European Clinical Trials Database record.
- 15 Sep 2011 Additional trial identifiers (NCT01432470, OxyPeP001), trial status (completed) and trial centres identified as reported by ClinicalTrials.gov.
- 12 Sep 2011 Additional location (Sweden) and actual initiation date (Aug 2010) identified as reported by ClinicalTrials.gov.